review the post and provide a reply as a possible DNP student, use real references from 2020-2026. NO ai use no plagiarsm

 300 words to PEtr APA 7 formatApproved PICOT QuestionAmong healthcare providers in an adult primary care clinic (P), how does implementation of the Infectious Diseases Society of America clinical practice guideline for asymptomatic bacteriuria through provider education, a clinical decision-making algorithm, and audit and feedback (I), compared with current practice (C), affect provider adherence to guideline recommendations and the rate of inappropriate antibiotic treatment for asymptomatic bacteriuria (O) over eight weeks (T)?Goals for the Week Week 3 has the primary objective of developing and reinforcing the use of the algorithm through routine experiences and examining whether the audit process captures clinical reasoning processes versus simply the results of culture. Building upon both the approved protocol developed from Week 1 (when preliminary provider education, the preimplementation knowledge survey, provision of the decision algorithm, and pilot chart audits were initially implemented), this week continues with the focus on using the algorithm for the healthcare providers involved, rather than enlisting patients as research participants. As previously stated, the results of the intervention include measuring provider compliance to recommendation guidelines and the rate of inappropriate antibiotic treatments prescribed for asymptomatic bacteriuria (ASB). Additionally, a secondary goal is to continue to develop clinical distinctions regarding ASB and symptomatic urinary tract infections (UTIs). As noted by the Infectious Diseases Society of America (IDSA), routine screening and treatment of ASB is not recommended for most nonpregnant populations, such as older adults and individuals with diabetes; however, screening and treatment may be appropriate in pregnant women and prior to specific endoscopic urological procedures associated with mucosal trauma. It is also important to note that having a positive culture does not equate to having a symptomatic UTI; similarly, pyuria cannot be used as a sole basis for initiating antibiotic treatment (Nicolle et al., 2019). The IDSA's criteria will serve as a foundation for all aspects of the algorithm and subsequent feedback. Activities Conducted/Planned This reporting period includes reviewing eligible encounters for documentation of indications for urine testing, symptoms documented before antibiotics were prescribed, and whether antibiotic prescribing decisions were consistent with IDSA exceptions. The initial staff education session was conducted as part of the Week 1 report; therefore, the session is being referenced again only as an established component and not as an activity initiated during Week 3. Any further education provided during Week 3 will be identified in the practicum record and documented as either a reinforcement or makeup session with confirmation of the date and participants. To ensure comparison across weeks, I will utilize the same approved algorithm, educational material, and audit variables. For each eligible encounter, chart review will assess the rationale for ordering a urine test, documented genitourinary and systemic symptoms, urine culture results when available, and whether an antibiotic was prescribed. In addition to assessing whether or not a decision is supported by IDSA, I will document whether symptoms were present but not documented in the record versus no symptoms were documented in the record. Records containing ambiguity will be identified in accordance with predetermined project parameters instead of relying on assumptions. Only aggregate, de-identified patterns will be utilized for providing educational feedback, and ambiguous classification will be reviewed with my preceptor. To ensure integration of these activities within normal patient care processes without establishing a separate clinical workflow, communication with my preceptor and clinic leaders will focus on methods for incorporating these activities into daily operations. The audit plan and feedback structure will be documented to allow members of my team to identify whether an intervention was delivered as intended or delayed modifications occurred. Published literature indicates that there are two key factors that contribute to translating IDSA recommendations for managing ASB into practice: effective design of the intervention(s) and adequate resources (Hojat et al., 2022). Monitoring these elements will assist in improving consistency in implementing interventions rather than concluding that changes in prescribing practices have already been realized.3. Positive Aspects of the week One positive aspect of this week is that using a structured approach allows us to see variations in the way clinicians order and prescribe drugs while avoiding identifying the clinician who has made the decision. We have established that there is interest from the provider, some level of leadership support, and an initial assessment of feasibility regarding the audit tool. While these represent good foundations, they do not provide assurance that we will have long-term commitment and improvements in subsequent weeks. Therefore, I will consider continued participation a positive only if attendance records, completed reviews, or documented interaction show it. It will continue to be clear that a successful implementation process does not equal a measurable clinical outcome.  The project provides a positive opportunity for the clinicians to engage in dialogue about when patients have commonly occurring bacteriuria; however, treatment is not required. Encouraging them to frame their discussions related to this issue as being part of their professional judgment  should create an environment conducive to sharing information. Essential III of the AACN DNP focuses on the evaluation and utilization of evidence, the assessment of practice patterns, and the use of quality-improvement techniques. Essential II includes the role of organizational leaders and accountability for ensuring quality and safe patient care (American Association of Colleges of Nursing [AACN]., 2006). The above-mentioned essential requirements are clearly met through both standardization of chart reviews and providing supportive feedback. 4. Unexpected Events or ChallengesThere is the potential in Week 3 for challenges with categorizing cases where the patients' symptoms are nonspecific or the data collected is insufficient. This scenario represents something to keep track of, not that it has happened. In Week 1 specific issues included conflicting schedules, variable documentation, and greater time spent abstracting charts than anticipated. I will assess whether these barriers exist currently based on the actual schedules provided, areas within the data collection tools that are missing, and the amount of time spent abstracting charts. If additional issues arise prior to my final discussion posting, I will detail what occurred, how it impacted implementation, and how the issue was resolved so that I am not attributing unsubstantiated findings to clinicians. Another consideration is determining whether antibiotics are appropriate. The review can’t conclude that each positive culture indicates treatment is warranted; nor can we determine that treatment was inappropriate simply because the note is short. A consistent review of pregnancy status, relevant urologic procedures, presence of symptoms associated with urinary tract infections, and other clinical context relative to the approved criteria is necessary. All unanswered documentation questions will be clearly tracked. This helps ensure our credibility, as the reduction in antibiotic orders isn't necessarily a sign that we've improved patient care unless we're also looking at clinical indicators.Adjustments for the Following WeekI will continue to collect data on the patient population (total patients, demographic characteristics) to allow for ongoing comparison of early vs. late project periods. Furthermore, I will document whether providers have direct access to view the algorithm at the point of their clinical decisions, if the feedback is reaching the appropriate providers, and if there is adequate "protected" time available to conduct audits/abstracts. My goal is to maintain fidelity to the original study design while implementing an intervention that is practical to implement in a high-volume adult primary care clinic. All adjustments will be documented along with the reason for each and the time they were implemented, so that subsequent analyses may consider variation in how much exposure each participant had to the intervention. This approach will support the production of a quality improvement report, rather than overestimating the degree of causality due to the limited amount of time we have to implement our intervention.Practicum Hours:Week 3: Total hours allocated for planning: 30 hours Site hours: 12 hours Non-site hours: 18 hours Non-site hours include: Evidence Review & Project Preparation, Data Quality Checks, Meetings with Mentor/Preceptor/Faculty, Documentation and other Scholarly Work. All Site Hours will be used for Provider Communication; Audit & Feedback, Algorithm Reinforcement & Chart Abstraction. All non-site hours will be reserved for eligible project-related scholarly activities and meetings only. Prior to submitting this report, I will ensure that my Practicum Log accurately reflects the calendar and all project documentation and update the Proposed Allocation to reflect the Actual Number of Hours Spent at the Site and the Total Cumulative Number Reported for the week.

References

American Association of Colleges of Nursing. (2006). The essentials of doctoral education for advanced nursing practice. https://www.aacnnursing.org/Portals/0/PDFs/Publications/DNPEssentials.pdfHojat, L., Saade, E., Hernandez, A., Donskey, C., & Deshpande, A. (2022). Can electronic clinical decision support systems improve the diagnosis of urinary tract infections? A systematic review and meta-analysis. Open Forum Infectious Diseases, 9(12), ofac691. https://doi.org/10.1093/ofid/ofac691Nicolle, L. E., Gupta, K., Bradley, S. F., Colgan, R., DeMuri, G. P., Drekonja, D., Eckert, L. O., Geerlings, S. E., Köves, B., Hooton, T. M., Juthani-Mehta, M., Knight, S. L., Saint, S., Schaeffer, A. J., Trautner, B. W., Wullt, B., & Siemieniuk, R. (2019). Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 68(10), e83–e110. https://doi.org/10.1093/cid/ciy1121